A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2004
12/02/2004	US20040243606 Hormonal contraceptive product
12/02/2004	US20040243226 Means and method for the treatment of coronary artery obstructions
12/02/2004	US20040243097 Antiproliferative drug and delivery device
12/02/2004	US20040242974 Treatment of refractory depression with an opiate antagonist and an antidepressant
12/02/2004	US20040242930 Treatment of heart rhythm disturbances with N6-substituted-5'-(N-substituted) carboxamidoadenosines
12/02/2004	US20040242928 Reverse hydroxamic acid derivatives
12/02/2004	US20040242913 A aromatic cyanoamide compound; pesticides; veterinary medicine
12/02/2004	US20040242904 Novel sordarin derivative isolated from culture fermentations and functions as an antifungal agent
12/02/2004	US20040242896 Azole compounds as anti-fungal agents
12/02/2004	US20040242890 Agonists of beta-adrenoceptors
12/02/2004	US20040242887 Hypotonic bladder diseases
12/02/2004	US20040242884 3-Substituted-7-oxo-4,7-dihydro-thieno(3,2-b)pyridine-6-carboxylic acid benzylamide derivatives; for herpes viruses
12/02/2004	US20040242873 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
12/02/2004	US20040242872 Method of preparing 4-(imidazole-1-yl)benzenesulphonamide derivatives
12/02/2004	US20040242871 Nitric oxide synthease inhibitors; antiinflamamtory agents; analgesics; inflamamtory bowel disorders; antiarthritic agents;
12/02/2004	US20040242868 Controlling cytokines; antiinflammatory agents; rheumatic disoreders; skin disorders; respiratory system disorders; Alzheimer's disease; Parkinson's disease; Huntington"s disease ; amyotrophic lateral sclerosis
12/02/2004	US20040242860 Compositions and methods for the diagnosis and treatment of tumor
12/02/2004	US20040242852 Bifunctional chelating agent for actinium
12/02/2004	US20040242705 administering 1-(4-chloro-3-methylsulphonylphenyl)-1 -(4-chlorophenyl)-2,2-dichloroethene containing a radio labelled halogen
12/02/2004	US20040242704 Administering to the vertebrate an opsin-binding synthetic retinoid in a pharmaceutically acceptable vehicle for restoring photoreceptor function in a vertebrate eye
12/02/2004	US20040242701 Amines as ant-alcoholism agents
12/02/2004	US20040242700 Administering a warm blood animal an ambroxol, bromhexin or salts or mixtures for treating influenza virus
12/02/2004	US20040242698 Analeptic and antidepressant combinations
12/02/2004	US20040242696 Anticancer agent having a quinone, quinone prodrug, catechol or catechol prodrug moiety; free of combretastatin A-1
12/02/2004	US20040242694 Remedial agent for cardiac failure
12/02/2004	US20040242692 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis
12/02/2004	US20040242691 Creatine oral supplementation using creatine hydrochloride salt
12/02/2004	US20040242689 Therapy of patients with orally administration of dosage of 1,3 cis- retinoic acid daily for initial treatment period, followed by a sustaining treatment by administering 13 cis- retinoic acid for five to seven days
12/02/2004	US20040242687 Thrombus/thrombogenesis inhibitors
12/02/2004	US20040242686 Crystals of hydroxynorephedrine derivative
12/02/2004	US20040242685 Administering -4-benzyloxy-3,5-dimethoxy-N-[(1-dimethylaminocyclopentyl)methyl]benzamide or derivatives for treating disorders responsive to inhibition of the GlyT-2 transporter, such as muscle spasticity, epilepsy and acute, chronic and neuropathic pain
12/02/2004	US20040242684 Method and compositions for inhibiting cell proliferative disorders
12/02/2004	US20040242683 Orally administering to the patient a therapeutically effective amount of S-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino)phenyl]2-methylpropanethioate in a pharmaceutical composition with food; use in treatment of cardiovascular disease, coronary heart disease, coronary artery disease
12/02/2004	US20040242682 Compositions comprising arginine and nitrates
12/02/2004	US20040242679 Methods and compositions for potentiating cancer chemotherapeutic agents
12/02/2004	US20040242678 Apolipo protein e secretion promoters
12/02/2004	US20040242677 Treatment of osteoporosis and autoimmune disease with astrogorgiadiol
12/02/2004	US20040242676 Method of mitigating the adverse effects of IL-2
12/02/2004	US20040242675 Compositions useful for the treatment of pathologies responding to the activation of PPAR-gamma receptor
12/02/2004	US20040242674 For example, (2'R,3'R)-13-[N-benzoyl-3-(2-furyl)-2-methyl-isoserinoyl]-baccatin III, (2'R,3'R)-13-[N-t-butoxycarbonyl-3-(2-furyl)-2-methyl-isoserinoyl]-baccatin III; antitumor activity against cancer cells of the breast, lung, ovary, colon, prostate, kidney, pancreas
12/02/2004	US20040242673 Heterocyclic compounds and uses thereof
12/02/2004	US20040242672 Pyrrolidine derivatives
12/02/2004	US20040242671 Use of 2-oxo-1-pyrrolidine derivatives for the preparation of a drug
12/02/2004	US20040242669 Method of treating deficits associated with brain injury
12/02/2004	US20040242668 Capable of increasing lipolysis and energy expenditure in cells and therefore is useful for treating Type 2 diabetes and/or obesity
12/02/2004	US20040242667 Method of using cyclooxegenase-2 inhibitors in the treatment and prevention of dementia
12/02/2004	US20040242664 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
12/02/2004	US20040242663 Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use
12/02/2004	US20040242661 Polymorphs of valsartan
12/02/2004	US20040242660 Combinations of oxazolidinones with other active ingredients for the prophylaxis and/or treatment of thromboembolic disorders
12/02/2004	US20040242659 Heterocyclic compounds, oxazole derivatives, process for preparation of the same and use thereof
12/02/2004	US20040242658 Recrystallizing rosiglitazone maleate from solvent; for treatment or prophylaxis of diabetes mellitus, conditions associated with diabetes mellitus and complication thereof in a mammal
12/02/2004	US20040242657 Reaction of a phenoxypropionic acid compound with a trifluoromethylphenylthiazole compound; for manufacture of a medicament for treatment of a human peroxisome proliferator activated receptor alpha mediated disease or condition such as hypercholesteremia, cardiovascular disease
12/02/2004	US20040242656 N-heterocyclicamide compounds; useful in the treatment of cardiovascular disorders, in particular, as an anticoagulant
12/02/2004	US20040242655 Compositions and methods for inhibiting an isoform of human manganese superoxide dismutase
12/02/2004	US20040242652 Beta benzyloxyaspartate derivatives with amino group on benzene ring
12/02/2004	US20040242651 to gastrointestal systems, kidneys
12/02/2004	US20040242650 Extended dosing regimen
12/02/2004	US20040242649 Extended dosing regimen
12/02/2004	US20040242647 Use of organic compounds
12/02/2004	US20040242644 Nicotinic acetylcholine receptors to treat pain
12/02/2004	US20040242640 Dual-release compositions of a cyclooxygenase-2 inhibitor
12/02/2004	US20040242639 Compounds such as 4-[4-(2-methoxyphenyl)-1-piperazinyl]-3-[[(phenylamino)carbonyl]amino]-benzamide, for therapy of restenosis
12/02/2004	US20040242638 Treatment of rhinitis with steroids as antiallergens
12/02/2004	US20040242637 drugs used for signal transduction modulation, and for prophylaxis of angiogenesis, cancers, tumors, atherosclerosis, vision disorders and inflammatory diseases in mammals
12/02/2004	US20040242636 Enzyme inhibitors as antiinflammatory ageents for psoriasis, obesity
12/02/2004	US20040242634 Cholinesterase admistered with inhibitors and kits
12/02/2004	US20040242633 Compound used to lower cholesterol, reduce weight for dietetics, antidepressants and antidiabetic agents
12/02/2004	US20040242632 Method for treating inflammatory bowel disease
12/02/2004	US20040242631 PI-3 kinase inhibitor prodrugs
12/02/2004	US20040242630 Dichlorinated heterocyclic compounds and methods of synthesis
12/02/2004	US20040242629 Quinuclidine carbamate derivatives and their use as M3 antagonists
12/02/2004	US20040242628 administering N-(1H-Indol-7-yl)-4-nitrobenzenesulfonamide; treating cachexia during cancer therapy
12/02/2004	US20040242627 2-Iminoimidazole derivatives (1)
12/02/2004	US20040242626 Nasal delivery of apomorphine
12/02/2004	US20040242625 Nasal delivery of apomorphine
12/02/2004	US20040242624 Nasal delivery of apomorphine
12/02/2004	US20040242622 Azabicycloalkane compounds
12/02/2004	US20040242621 Method of treating hepatic fibrosis
12/02/2004	US20040242620 Immune response modifier compounds for treatment of TH2 mediated and related diseases
12/02/2004	US20040242619 Processes for preparation of polymorphic forms of desloratadine
12/02/2004	US20040242618 Anticancer agents for prevention of cancer as agonist and antiandrogens
12/02/2004	US20040242617 Combination of selected opioids with muscarine antagonists for treating urinary incontinence
12/02/2004	US20040242616 reducing the central nervous system activity of a morphine-like opioid, comprising linking the nitrogen atom of the morphine-like opioid to a radical
12/02/2004	US20040242615 enhancing the expression of apoAI; prevention or therapy of dislipidemia
12/02/2004	US20040242613 Pyrimidine derivatives useful as inhibitors of PKC-theta
12/02/2004	US20040242612 Use of tyrosine kinase inhibitors for promoting hair growth
12/02/2004	US20040242610 A cis isomer of 1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-5-fluorocytosine has potent activity against hepatitis B virus infection; administration by rectal, nasal, topical, transdermal, vaginal, parenteral, intravenous injection
12/02/2004	US20040242606 Anti-cancer cyclopenta (g)quinazoline compounds
12/02/2004	US20040242605 Medicine containing pyrimidine derivative
12/02/2004	US20040242603 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor and medicinal composition containing the same
12/02/2004	US20040242602 Novel thiazolidine compounds as calcium sensing receptor modulators
12/02/2004	US20040242601 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis
12/02/2004	US20040242600 tyrosine kinase inhibitors; for the treatment especially of a proliferative disease, such as a tumur
12/02/2004	US20040242599 Cyclopentene nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
12/02/2004	US20040242598 Phosphodiesterase 4 inhibitors
12/02/2004	US20040242597 Combination
12/02/2004	US20040242596 such as N-(3-Amino-propyl)-N-[1-(5-benzyl-3-methyl-4-oxo-4,5-dihydro-isothiazolo[5,4-d]pyrimidin-6-yl)-propyl]-4-chloro-benzamide; for interrupting mitosis; antiproliferatives and anticancer agents
12/02/2004	US20040242595 Pyrimidine derivatives
12/02/2004	US20040242594 Prodrugs of antidepressants and their use for treating depressions

1 ... 4871 4872 4873 4874 4875 4876 4877 4878 4879 4880 4881 4882 4883 4884 4885 4886 4887 4888 4889 4890 4891 ... 7860